X hits on this document

452 views

0 shares

0 downloads

0 comments

11 / 170

10

2

Washington Hospital Centre and Professor of Medicine at Georgetown University in

3

Washington DC.

1

DR. BURMAN: Ken Burman, Chief of Endocrinology at the

4

DR. TRAN: Paul Tran, Designated Federal Official for the EMDAC

5

6

Advisory committee.

DR. LEVITSKY: Lynne Levitsky, pediatric endocrinology,

7

Massachusetts General Hospital.

8

DR. WYNE: Kathleen Wyne, endocrinologist, the Methodist Hospital

9

Research Institute, Weill Cornell Medical College, Houston, Texas.

10

DR. TEERLINK: John Teerlink, Professor of Medicine, University of

11

California, San Francisco and cardiologist at San Francisco VA Medical Center.

12

DR. KILLION: I am Rebecca Killion; I am a patient representative and a

13

type 1 diabetic.

14

DR. SAVAGE: Peter Savage. I am an endocrinologist at NIDDK and

15

prior to being there for the last year and a half, I was at the NHLBI.

16

DR. LESAR: Timothy Lesar, Director of Clinical Pharmacy Services,

17

Albany, New York and New Drug Safety and Risk Management Committee.

18

DR. VELTRI: Rick Veltri, Schering-Plough Research Institute, industry

19

representative.

20

DR. FELNER: Eric Felner, pediatric endocrinologist at Emory University

21

in Atlanta.

22

DR. ROSEBRAUGH: Curtis Rosebraugh, Director, Office of Drug

23

Evaluation.

Scribes, LLC Toll Free 1-800-675-8846 www.scribesllc.com

Document info
Document views452
Page views452
Page last viewedMon Dec 05 17:01:10 UTC 2016
Pages170
Paragraphs7975
Words54271

Comments